Br J Fam Plann 1980
Please contact us at any time for more information
This reduced variability may provide benefits beyond what average glucose levels indicate, since glucose fluctuations themselves appear to contribute to metabolic dysfunction and vascular damage
Keywords: Icotrokinra, Immune-mediated inflammatory disease, Interleukin-23, Oral peptide delivery, Oral systemic peptide, Peptide therapeutics Key Summary Points Introduction Immune-mediated inflammatory diseases (IMIDs), such as psoriasis, psoriatic arthritis, and inflammatory bowel disease (IBD), which includes Crohns disease and ulcerative colitis, encompass a heterogenous group of conditions associated with chronic inflammation [1]
26 Biochemical abnormalities commonly seen in patients with ASD include impaired methylation, sulphation capacities and low glutathione (GSH) redox capacity, all of which can potentially respond to B12 supplementation
doi:10.1007/s00210-022-02280-w